Cancer Res 1995, 55:2665–2672.PubMed 23. Feldman RA, Deeks JJ, Evans SJ: Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995, 14:428–433.PubMedCrossRef 24. Crowther JR: ELISA: Theory and Practice. In Methods in Molecular Biology. Totowa: Humana Press; 1995:42. 25. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990, 9:1595–1902.PubMed 26. Farinati F, Cardin R, Russo VM, Busatto G, et al.: Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction URMC-099 price and at the gastric
antrum. Cancer Epidemiology, Biomarkers & Prevention 2004,13(11):1722–8. 27. El-Darahali A, Fawcett H, Mader JS, Conrad
DM, Hoskin DW: Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor. Experimental & Molecular Pathology 2005,79(3):249–58.CrossRef 28. Hellman NE, Gitlin JD: Ceruloplasmin metabolism and function. Annual Review of Nutrition 2002, 22:439–58.PubMedCrossRef 29. Sima AA, LeWitt PA: Ceruloplasmin immunoreactivity in neurodegenerative disorders. Free Radical Research 2001,35(2):111–8.PubMedCrossRef 30. McCord J: The evolution of free radicals and oxidative mTOR inhibitor stress. Am J Med 2000,108(8):652–659.PubMedCrossRef 31. Davies GR, Simmonds NJ, Stevens TRJ, Grandison A, Blake DR, Rampton DS: Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992, 33:1467–1472.PubMedCrossRef 32. Takahashi N, Ortel TL, Putmam FW: Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc Natl Acad Sci 1984, 81:390–394.PubMedCrossRef 33. Lauren P: The two histologic main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965, 64:31–49.PubMed 34. Sobin LH, Wittekind CH, editors: UICC: TNM Classification of malignant tumors. 5th edition. Berlin: Springer-Verlag; 2000.
35. Andersen LP, Raskov H, Elsborg L, et al.: Prevalence of antibodies against heat-stable antigens from Helicobacter pylori Terminal deoxynucleotidyl transferase in patients with dyspeptic symptoms and normal persons. Acta Pathol Microbiol Immunol Scand 1992, 100:779–789. 36. Senra Varela A, Lopez Saez JB, Quintela Senra D: Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Letters 1997, 121:139–145.PubMedCrossRef 37. SPSS for windows. SPSS Inc. Chicago, IL; 1989. 38. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP, Tham KT, Camorlinga M, Blaser MJ, Falkow S, Peek RM Jr: Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001, 107:611–620.PubMedCrossRef 39.